By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in ...

Whether in China or the United States, AstraZeneca's chief exec Pascal Soriot (pictured) knows how to capture headlines.

AstraZeneca made a big commitment to China as CEO Pascal Soriot joined British Prime Minister Keir Starmer on a trip to the ...

AstraZeneca PLC (NASDAQ:AZN) is one of the stocks Jim Cramer shed light on recently. When a caller mentioned that they are ...

AstraZeneca's decision to invest more than 100 billion yuan ($14.39 billion) in China by 2030 marks a new chapter for the British drug-maker in a market it increasingly sees as central to global ...

AstraZeneca announces a $15B China investment through 2030 to expand manufacturing and R&D in cell therapy and radioconjugates—read the full update now.

By Andrew MacAskill LONDON, Jan 26 (Reuters) - UK-headquartered pharmaceutical firm AstraZeneca's CEO Pascal Soriot will join ...

British pharmaceutical group AstraZeneca said Thursday that it would invest $15 billion in China through 2030 to expand its ...

By Andrew MacAskill, Maggie Fick and Bhanvi Satija LONDON, Jan 26 (Reuters) - UK-based drugmakers AstraZeneca and GSK will ...

On Saturday, 31 January, the China-Britain Business Council (CBBC) and the British Chamber of Commerce Shanghai (BritCham ...

Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial ...